Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

F-calprotectin and blood markers correlate to Quality of Life in Pediatric Inflammatory Bowel Disease

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Extraintestinal Manifestations are Associated with Disease Severity in Pediatric Onset Inflammatory Bowel Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Preterm Birth Has Effects on Gut Colonization in Piglets Within the First 4 Weeks of Life

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Serum Calprotectin in Adolescents with Inflammatory Bowel Disease - A Pilot Investigation

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Bovine Colostrum For Preterm Infants in the First Days of Life: A Randomized Controlled Pilot Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Extraintestinal Manifestations are Associated with Disease Severity in Pediatric Onset Inflammatory Bowel Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Letter: suicide risk among adult inflammatory bowel disease patients. Authors' reply

    Research output: Contribution to journalLetterResearchpeer-review

  4. Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVES: Our aim was to investigate predictors of Health Related Quality of Life (HRQoL) with respect to changes in disease parameters over time in children with Inflammatory Bowel Disease (IBD).

METHODS: This was a prospective longitudinal study examining the association between HRQoL (IMPACT III) and symptom scores (PCDAI, abbrPUCAI), fecal calprotectin (FC) measures and blood analyses (C-reactive protein [CRP], erythrocyte sedimentation-rate [ESR], orosomucoid [ORM], albumin [ALB], hemoglobin [HB] and vitamin-D [VIT-D]) in a cohort of 10-17 years old IBD patients. Data were collected prospectively at three-month intervals during a two-year period. Associations were analyzed using linear Mixed Effect Models. Patients were divided into two groups which received Non-biological oral treatment or Biological parenteral treatment.

RESULTS: From 79 patients (39 Crohn Disease [CD]/ 40 ulcerative colitis [UC]), representing a total of 43,132 days of observation, 572 IMPACT measurements were paired with variables. A decrease in the IMPACT III score was significantly associated with increased UC-symptom score in the Biological group (P = 0.005), and a similar inverse tendency was found in the Non-biological group and for CD-symptoms in both groups. We found in both treatment groups overall a significant (P < 0.05) inverse association between the IMPACT III and the levels of FC, ESR and ORM whereas ALB, HB and VIT-D were directly significant associated.

CONCLUSIONS: The IMPACT score, already known to correlate with disease activity, has now been shown to be associated with disease markers in feces and blood. This emphasizes that objective markers of disease activity indirectly can predict the patient's HRQoL.

Original languageEnglish
JournalJournal of Pediatric Gastroenterology and Nutrition
Volume65
Issue number5
Pages (from-to)539-545
ISSN0277-2116
DOIs
Publication statusPublished - Nov 2017

    Research areas

  • Journal Article

ID: 49918837